There are over 100 clinical trials available to the Columbus area through the Columbus Regional Research Institute (CRRI). Of that, half of these trials are committed to the study and treatment of cancer. That is why CRRI and IACT Health, and the John B. Amos Cancer Center are pleased to announce a strategic partnership in the field of oncology research. This new partnership will dramatically expand the scope of cancer research in the Southeast Region.

“There is no doubt that the future of healthcare rests heavily on the advances that can be gained only through dedicated, systematic research,” said Scott Hill, President and CEO of Columbus Regional Health (CRH). CRH’s John B. Amos Cancer Center is currently on the leading edge of cancer research as they are involved in the Georgia NCI Community Oncology Research Program – a six-center statewide network dedicated to encouraging cancer treatment through trials within the community.

Clinical trials have been proven to be beneficial to volunteers in more ways than one. Volunteers receive benefits such as specialized care, a more in-depth diagnosis of their condition and access to cutting-edge treatments before they are released for international use. But perhaps the biggest benefit is that all of this comes at no cost to the patient.

Both IACT and CRH strongly believe that oncology research is the pathway to improving how cancer is treated – and potentially cured.

“The physicians at the John B. Amos Cancer Center are totally committed to delivering the highest levels of leading-edge care for their patients and they understand the value of research in providing that care,” said Dr. Jeff Kingsley, of IACT Health. “They have been researching cancer treatment breakthroughs for well over a decade and we are thrilled to help them accelerate this important work.”

With this partnership, IACT Health will be the exclusive facilitator for all clinical trials taking place at the John B. Amos Cancer Center. The two organizations expect to more than double the number of cancer-related studies currently taking place at the center.

For more information on clinical trials, contact the Columbus Regional Research Institute at (706) 321-0495.